- Home
- TEL vs EW Comparison
TEL vs EW Comparison
Compare TEL & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TEL | EW |
|---|---|---|
| Founded | 1941 | 1958 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.9B | 49.9B |
| IPO Year | 2007 | 1999 |
Fundamental Metrics
Financial Performance| Metric | TEL | EW |
|---|---|---|
| Price | $196.49 | $94.80 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 21 |
| Target Price | ★ $257.27 | $96.37 |
| AVG Volume (30 Days) | 2.3M | ★ 4.0M |
| Earning Date | 04-22-2026 | 04-23-2026 |
| Dividend Yield | ★ 1.38% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 5.42 | 0.66 |
| Revenue | ★ $17,262,000,000.00 | $6,067,600,000.00 |
| Revenue This Year | $14.07 | $13.39 |
| Revenue Next Year | $7.74 | $9.81 |
| P/E Ratio | ★ $36.55 | $143.65 |
| Revenue Growth | 8.94 | ★ 11.55 |
| 52 Week Low | $173.55 | $72.30 |
| 52 Week High | $252.56 | $96.29 |
Technical Indicators
Market Signals| Indicator | TEL | EW |
|---|---|---|
| Relative Strength Index (RSI) | 40.82 | 69.85 |
| Support Level | $193.05 | $82.02 |
| Resistance Level | $216.51 | N/A |
| Average True Range (ATR) | 5.91 | 2.36 |
| MACD | -0.94 | 0.61 |
| Stochastic Oscillator | 8.67 | 86.42 |
Price Performance
Historical ComparisonAbout TEL TE Connectivity Ltd. New Switzerland Registered Shares
TE Connectivity is the largest electrical connector supplier in the world, supplying interconnect and sensor solutions to the transportation, industrial, and communications markets. With operations in 150 countries and over 500,000 stock-keeping units, TE has a broad portfolio that forms the electrical architecture of its end customers' cutting-edge innovations.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.